Coeur d' Alene Bancorp
CDAB · OTC
About CDAB
- Employees
- 0
- Headquarters
- COEUR D ALENE, Idaho
- Listed
- Nov 2, 2018
- Sector
- Financials
- Industry
- Banks
- Website
- bankcda.com
CDAB key statistics
- Market cap
- 29.50M
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 5.16K
- Volume
- 3.76K
- Open price
- $15.55
- High today
- $15.60
- Low today
- $15.35
- 52 Week high
- $17.36
- 52 Week low
- $15.35
Coeur d' Alene Bancorp (CDAB) at a glance
As of Oct 8, 2026, Coeur d' Alene Bancorp (CDAB) shares are priced at $15.60, giving the company a market cap of 29.50M.
Today the stock has traded between $15.35 and $15.60. The current price is 1.6% above the day's low and 0.0% below its high.
Volume so far is 3.76K shares, below the average of 5.16K shares a day.
Over the past year Coeur d' Alene Bancorp has ranged from $15.35 to $17.36, and now sits 12% of the way up that range.
Similar companies
Companies in the same industry as Coeur d' Alene Bancorp
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002−20.00%
- SHFSSHF Holdings$0.1677+86.54%
- SXTCChina SXT Pharmaceuticals$0.0762+16.69%
- SNWRSanwire$0.0003+0.00%
- OLOXOlenox Industries$1.13+53.49%
- RBNERobin Energy$1.00+151.38%
- WHLRWheeler Real Estate Investment Trust$0.4284+19.10%
- WFFWF Holding$0.0982+5.71%
- NBNDNetBrands$0.0009−9.09%
- SPCXSpace Exploration Technologies$161.87+9.53%
- SDSTStardust Power$0.018−10.00%
- SEIISharing Economy International$0.0004+0.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.50−0.57%
- CTYCITY THERAPEUTICS$20.20−3.02%
- IAMIambic Therapeutics$15.78−1.47%
- AMROAmaero$5.54−2.55%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.10−2.35%
- RTSNRetension Pharmaceuticals$16.18+0.00%
- PAXGUPine Tree Acquisition$9.96−0.17%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.51+1.60%
- RZAIROZE AI$10.59+2.97%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.